These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8447600)

  • 1. Transfusion: morbidity and mortality.
    Nicholls MD
    Anaesth Intensive Care; 1993 Feb; 21(1):15-9. PubMed ID: 8447600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trend in ABO-incompatible RBC transfusion-related fatalities reported to the FDA, 2000-2019.
    Storch EK; Rogerson B; Eder AF
    Transfusion; 2020 Dec; 60(12):2867-2875. PubMed ID: 33064880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-Associated Circulatory Overload: Evidence-Based Strategies to Prevent, Identify, and Manage a Serious Adverse Event.
    Henneman EA; Andrzejewski C; Gawlinski A; McAfee K; Panaccione T; Dziel K
    Crit Care Nurse; 2017 Oct; 37(5):58-65. PubMed ID: 28966196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital.
    Domen RE
    Transfusion; 1998 Mar; 38(3):296-300. PubMed ID: 9563411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reports of 355 transfusion-associated deaths: 1976 through 1985.
    Sazama K
    Transfusion; 1990 Sep; 30(7):583-90. PubMed ID: 2402771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Root cause analysis of non-infectious transfusion complications and the lessons learnt.
    Karim F; Moiz B; Shamsuddin N; Naz S; Khurshid M
    Transfus Apher Sci; 2014 Feb; 50(1):111-7. PubMed ID: 24239270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consecutive national surveys of ABO-incompatible blood transfusion in Japan.
    Fujii Y; Shibata Y; Miyata S; Inaba S; Asai T; Hoshi Y; Takamatsu J; Takahashi K; Ohto H; Juji T; Sagawa K
    Vox Sang; 2009 Oct; 97(3):240-6. PubMed ID: 19476605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The German Haemovigilance System--reports of serious adverse transfusion reactions between 1997 and 2007.
    Keller-Stanislawski B; Lohmann A; Günay S; Heiden M; Funk MB
    Transfus Med; 2009 Dec; 19(6):340-9. PubMed ID: 19725904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emergency compatible, ABO-different blood group transfusion in the operating theater: a survey in regional Japanese Society of Anesthesiologists-certified training hospitals in 2006].
    Irita K; Inada E; Tsuzaki K; Inaba S; Handa M; Kino S; Mashiko K; Kubo T; Morita K
    Masui; 2009 Aug; 58(8):1045-54. PubMed ID: 19702231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.
    Berséus O; Boman K; Nessen SC; Westerberg LA
    Transfusion; 2013 Jan; 53 Suppl 1():114S-123S. PubMed ID: 23301963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current state of transfusion practices for ABO-incompatible pediatric heart transplant patients in the United States and Canada.
    Dean CL; Sullivan HC; Stowell SR; Fasano RM; West LJ; Robitaille N; Josephson CD
    Transfusion; 2018 Sep; 58(9):2243-2249. PubMed ID: 30145826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Awareness of risk for transfusion reactions important for appropriate treatment].
    Lubenow N; Auvinen MK
    Lakartidningen; 2021 Mar; 118():. PubMed ID: 33720383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents.
    Bolton-Maggs PH
    Transfus Med; 2016 Dec; 26(6):401-405. PubMed ID: 27995700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.
    Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM
    Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risks associated with blood and blood product transfusion.
    Higgins C
    Br J Nurs; 2000 Dec 8-2001 Jan 10; 9(22):2281-90. PubMed ID: 12271194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How clinicians can minimize transfusion-related adverse events?
    Aubron C; Aries P; Le Niger C; Sparrow RL; Ozier Y
    Transfus Clin Biol; 2018 Nov; 25(4):257-261. PubMed ID: 30197000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history.
    Kato H; Nakayama T; Uruma M; Okuyama Y; Handa M; Tomiyama Y; Shimodaira S; Takamoto S
    Vox Sang; 2015 Apr; 108(3):243-50. PubMed ID: 25536173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse transfusion reactions in recipients transfused in out-of-hospital.
    Moncharmont P; Barday G; Odent-Malaure H; Benamara H;
    Transfus Clin Biol; 2018 May; 25(2):105-108. PubMed ID: 29555413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedside transfusion errors: analysis of 2 years' use of a system to monitor and prevent transfusion errors.
    Mercuriali F; Inghilleri G; Colotti MT; Farè M; Biffi E; Vinci A; Podico M; Scalamogna R
    Vox Sang; 1996; 70(1):16-20. PubMed ID: 8928485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present state of transfusion errors].
    Murakami J
    Rinsho Byori; 2003 Jan; 51(1):43-9. PubMed ID: 12652690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.